Industry stocks

Biotechnology Stocks on NASDAQ

Compare NASDAQ-listed Biotechnology stocks by fair value, valuation, financial quality, profitability, risk, and market outlook.

ACADIA Pharmaceuticals Inc (ACAD)
Fair Value34.1% Upside Undervalued Analyst43.7% Upside Market Cap3.66 B P/E10.1x Yield0.0% HealthGreat
  NASDAQ
Achieve Life Sciences Inc (ACHV)
Fair Value6.9% Upside Fair Analyst122.0% Upside Market Cap656 M P/E— Yield0.0% HealthFair
  NASDAQ
Agenus Inc (AGEN)
Fair Value24.7% Upside Undervalued Analyst308.9% Upside Market Cap289.9 M P/E3.2x Yield0.0% HealthGood
  NASDAQ Featured in High-Growth Small-Cap Stocks
Alaunos Therapeutics Inc (TCRT)
Fair Value-9.3% Downside Fair Market Cap4.674 M P/E— Yield0.0% HealthWeak
  NASDAQ
Alkermes Plc (ALKS)
Fair Value-5.4% Downside Fair Analyst26.2% Upside Market Cap7.485 B P/E— Yield0.0% HealthGood
  NASDAQ
Alnylam Pharmaceuticals Inc (ALNY)
Fair Value26.9% Upside Undervalued Analyst93.1% Upside Market Cap20.983 B P/E7.9x Yield0.0% HealthGreat
  NASDAQ
Alterity Therapeutics Ltd (ATHE)
Fair Value-5.4% Downside Fair Analyst496.8% Upside Market Cap45.283 M P/E— Yield0.0% HealthFair
  NASDAQ
Altimmune Inc (ALT)
Fair Value42.1% Upside Undervalued Analyst768.6% Upside Market Cap383.2 M P/E— Yield0.0% HealthFair
  NASDAQ
Amgen Inc (AMGN)
Fair Value1.9% Upside Fair Analyst-12.2% Downside Market Cap249 B P/E26.5x Yield2.1% HealthGreat
  NASDAQ
Anika Therapeutics Inc (ANIK)
Fair Value-3.6% Downside Fair Analyst19.0% Upside Market Cap258.7 M P/E— Yield0.0% HealthGood
  NASDAQ Featured in High-Momentum Stocks
Arrowhead Pharmaceuticals Inc (ARWR)
Fair Value6.3% Upside Fair Analyst87.5% Upside Market Cap8.114 B P/E— Yield0.0% HealthGood
  NASDAQ
Assembly Biosciences Inc (ASMB)
Fair Value19.5% Upside Undervalued Analyst156.0% Upside Market Cap407.2 M P/E— Yield0.0% HealthGreat
  NASDAQ Featured in High-Growth Small-Cap Stocks
ATyr Pharma Inc (ATYR)
Fair Value10.5% Upside Fair Market Cap14.787 M P/E— Yield0.0% HealthWeak
  NASDAQ
Bio Green Med Solution Inc (BGMS)
Fair Value14.4% Upside Fair Market Cap5.729 M P/E— Yield0.0% HealthFair
  NASDAQ
BioCryst Pharmaceuticals Inc (BCRX)
Fair Value19.7% Upside Undervalued Analyst169.3% Upside Market Cap1.944 B P/E— Yield0.0% HealthGreat
  NASDAQ
Biogen Inc (BIIB)
Fair Value8.3% Upside Fair Analyst8.6% Upside Market Cap36.058 B P/E103.7x Yield0.0% HealthGood
  NASDAQ
BioLineRx Ltd (BLRX)
Fair Value3.6% Upside Fair Market Cap9.32 M P/E— Yield0.0% HealthFair
  NASDAQ
Biomarin Pharmaceutical Inc (BMRN)
Fair Value32.0% Upside Undervalued Analyst62.2% Upside Market Cap10.87 B P/E— Yield0.0% HealthGood
  NASDAQ
Celldex Therapeutics Inc (CLDX)
Fair Value-15.2% Downside Fair Analyst123.1% Upside Market Cap2.219 B P/E— Yield0.0% HealthFair
  NASDAQ
Coherus BioSciences Inc (CHRS)
Fair Value51.5% Upside Bargain Analyst934.7% Upside Market Cap115.7 M P/E— Yield0.0% HealthFair
  NASDAQ
Compugen Ltd (CGEN)
Fair Value22.1% Upside Undervalued Analyst139.6% Upside Market Cap182.8 M P/E5.2x Yield0.0% HealthExcellent
  NASDAQ Featured in Financially Strong Value
Curis Inc (CRIS)
Fair Value-1.2% Downside Fair Market Cap3.436 M P/E— Yield0.0% HealthWeak
  NASDAQ
Cytokinetics Inc (CYTK)
Fair Value14.2% Upside Fair Analyst93.3% Upside Market Cap7.735 B P/E— Yield0.0% HealthFair
  NASDAQ
Fortress Biotech Inc (FBIO)
Fair Value66.8% Upside Bargain Analyst171.7% Upside Market Cap60.866 M P/E0.6x Yield0.0% HealthGreat
  NASDAQ
Geron Corporation (GERN)
Fair Value26.0% Upside Undervalued Analyst281.5% Upside Market Cap612.1 M P/E— Yield0.0% HealthGood
  NASDAQ
Gilead Sciences Inc (GILD)
Fair Value-18.4% Downside Overvalued Analyst2.9% Upside Market Cap207.9 B P/E— Yield1.9% HealthGood
  NASDAQ
Grifols SA ADR (GRFS)
Fair Value16.1% Upside Fair Analyst22.5% Upside Market Cap7.534 B P/E13.7x Yield2.6% HealthGood
  NASDAQ
Gyre Therapeutics Inc (GYRE)
Fair Value12.3% Upside Fair Analyst365.5% Upside Market Cap424.7 M P/E— Yield0.0% HealthFair
  NASDAQ
Halozyme Therapeutics Inc (HALO)
Fair Value1.8% Upside Fair Analyst-11.4% Downside Market Cap13.945 B P/E33.7x Yield0.0% HealthGreat
  NASDAQ
ImmuCell Corporation (ICCC)
Fair Value-21.7% Downside Overvalued Market Cap89.687 M P/E114.8x Yield0.0% HealthGreat
  NASDAQ
Imunon Inc (IMNN)
Fair Value6.0% Upside Fair Market Cap4.859 M P/E— Yield0.0% HealthWeak
  NASDAQ
Incyte Corporation (INCY)
Fair Value24.7% Upside Undervalued Analyst10.9% Upside Market Cap24.048 B P/E59.6x Yield0.0% HealthGreat
  NASDAQ Featured in Financially Strong Value
Insmed Inc (INSM)
Fair Value-8.8% Downside Fair Analyst78.5% Upside Market Cap23.855 B P/E— Yield0.0% HealthFair
  NASDAQ
Ionis Pharmaceuticals Inc (IONS)
Fair Value2.7% Upside Fair Analyst116.8% Upside Market Cap6.445 B P/E— Yield0.0% HealthFair
  NASDAQ
Ironwood Pharmaceuticals Inc (IRWD)
Fair Value8.9% Upside Fair Analyst51.4% Upside Market Cap666.7 M P/E5.1x Yield0.0% HealthGreat
  NASDAQ
Kazia Therapeutics Ltd ADR (KZIA)
Fair Value-1.5% Downside Fair Analyst313.5% Upside Market Cap95.926 M P/E— Yield0.0% HealthFair
  NASDAQ
Lisata Therapeutics Inc (LSTA)
Fair Value4.1% Upside Fair Analyst303.4% Upside Market Cap9.056 M P/E— Yield0.0% HealthFair
  NASDAQ
Madrigal Pharmaceuticals Inc (MDGL)
Fair Value30.5% Upside Undervalued Analyst71.5% Upside Market Cap9.326 B P/E— Yield0.0% HealthFair
  NASDAQ
MannKind Corp (MNKD)
Fair Value4.3% Upside Fair Analyst115.0% Upside Market Cap1.206 B P/E— Yield0.0% HealthGood
  NASDAQ
MediciNova Inc (MNOV)
Fair Value1.3% Upside Fair Analyst469.0% Upside Market Cap71.371 M P/E— Yield0.0% HealthFair
  NASDAQ Featured in High-Momentum Stocks Bullish Trend Stocks
Myriad Genetics Inc (MYGN)
Fair Value12.3% Upside Fair Analyst-28.7% Downside Market Cap602 M P/E— Yield0.0% HealthGood
  NASDAQ
Neurocrine Biosciences Inc (NBIX)
Fair Value31.0% Upside Undervalued Analyst29.9% Upside Market Cap16.171 B P/E23.0x Yield0.0% HealthGreat
  NASDAQ
Novavax Inc (NVAX)
Fair Value-17.8% Downside Fair Analyst47.7% Upside Market Cap1.613 B P/E— Yield0.0% HealthGood
  NASDAQ
Oncolytics Biotech Inc (ONCY)
Fair Value3.6% Upside Fair Analyst895.9% Upside Market Cap57.15 M P/E— Yield0.0% HealthWeak
  NASDAQ
Oruka Therapeutics Inc (ORKA)
Fair Value-41.2% Downside Overvalued Analyst62.6% Upside Market Cap6.357 B P/E— Yield0.0% HealthGood
  NASDAQ Featured in High-Momentum Stocks
Pluri Inc (PLUR)
Fair Value25.1% Upside Undervalued Analyst908.4% Upside Market Cap14.689 M P/E— Yield0.0% HealthWeak
  NASDAQ
Rigel Pharmaceuticals Inc (RIGL)
Fair Value33.0% Upside Undervalued Analyst37.8% Upside Market Cap853.9 M P/E2.7x Yield0.0% HealthExcellent
  NASDAQ Featured in High-Growth Small-Cap Stocks
Sarepta Therapeutics Inc (SRPT)
Fair Value30.1% Upside Undervalued Analyst23.1% Upside Market Cap1.855 B P/E— Yield0.0% HealthGreat
  NASDAQ
Explore listed stocks on NASDAQ with company information and fair value data.